Nav: Home

Protective protein activated by vitamin K found, inactive, abundant in blacks on dialysis

May 15, 2018

AUGUSTA, Ga. (May 15, 2018) - High levels of a protein activated by vitamin K and associated with cardiovascular disease when it isn't, has been found in the blood of African-Americans on dialysis, investigators report.

The work, published in the American Journal of Hypertension, indicates that these high blood levels of inactive matrix Gla protein, or MGP, may help identify those at highest risk for disease and who might benefit most from vitamin K supplementation, says Mary Ellen Fain, student at the Medical College of Georgia at Augusta University and the study's first author.

Active MGP appears to be the only natural inhibitor of vascular calcification and vitamin K the only known activator of MGP.

When MGP is active, calcium also circulating in the blood, binds to it - instead of the lining of blood vessel walls - so it gets eliminated by the body.

"We know that the lifespan of patients on hemodialysis is reduced, that cardiovascular disease accounts for about half their deaths and that vascular calcification is a key contributor," says Dr. Norman Pollock, bone biologist at MCG's Georgia Prevention Institute.

"Key questions we want to answer include exactly how vascular calcification occurs in this very high-risk population of individuals and how we might better recognize, treat and ideally prevent these unhealthy changes to their blood vessels," says Pollock, the study's corresponding author.

Inactive MGP is what's circulating in the blood, and the investigators measured those levels in 37 African-Americans on hemodialysis as well as 37 age and race matched healthy individuals. In people on hemodialysis, they also measured arterial stiffness as well as endothelial function, based on the ability of their blood vessels to perform basic functions like expand and contract in response to the body's demands.

They found mean levels of inactive MGP were 5.6 times higher than in healthy controls and those high levels correlated with increased arterial stiffness and impaired endothelial function, Fain says.

She notes that like vitamin K levels, vascular calcification is difficult to measure directly, so they measured these two related indicators of cardiovascular health.

The MCG study appears to be the first to look at the relationship between circulating levels of inactive MGP and these markers in this very high-risk group. The deleterious impact on cardiovascular health they found held even after adjusting for other established risks like diabetes and high body mass index and blood pressure.

Next steps include recruiting both black and white adults with stage 3 to 5 kidney disease who are on hemodialysis to look at the cardiovascular impact of taking a vitamin K supplement daily for two months.

Just why the balance of active versus inactive MGP is off in these patients is unknown, but these individuals may simply need more vitamin K to maintain sufficient levels of active MGP, Pollock says.

He notes that their colleagues at R&D Group VitaK, at Maastricht University in The Netherlands, have shown that kidney dialysis does not affect vitamin K levels. Higher calcium levels in the blood also are not a guarantee of vascular calcification, Fain adds.

Heart disease and kidney disease are among the leading causes of death in the United States, according to the Centers for Disease Control and Prevention. African-Americans are among those at highest risk for both, and kidney failure significantly increases the risk of heart disease.

Vascular calcification occurs most extensively in individuals with chronic kidney disease, the investigators write, particularly in those on hemodialysis, which is considered lifesaving in patients whose kidneys have failed.

Vitamin K is active only about six hours after it's consumed, and is found in green leafy vegetables like spinach, cabbage and lettuce as well as olive oil.

There's increasing evidence that the vitamin, better known for its role in bone health, has a role in cardiovascular health as well. Calcium is typically important for strong bone, and that's where we store most of it. It even normally helps blood vessels with their usual contraction and relaxation in response to your body's demands. But with vascular calcification, there is a double whammy as calcium gets pulled out of bones so they get weaker, and deposited in blood vessel walls which become stiff.

Although not yet used clinically, the circulating, inactive MGP measured in the newly published studies is widely considered an indicator of cardiovascular risk. Additionally, measuring inactive MGP levels is the only way currently available to gauge vitamin K levels, which cannot be measured directly, Pollock says.

In October 2017, Pollock and Fain published a study in The Journal of Nutrition that showed otherwise healthy teens who consumed the least vitamin K had 3.3 times higher risk of an enlargement of the pumping chamber of their hearts and that the chamber pumped out less blood.
-end-
For more information about the clinical trial of a vitamin K supplement, call Celestine Williams at 706-721-8553.

The published research was supported in part by the American Heart Association.

Medical College of Georgia at Augusta University

Related Cardiovascular Disease Articles:

More patients with cardiovascular disease now die at home than in the hospital
In a new study, Haider Warraich, MD, of Brigham and Women's Hospital, and colleagues assessed place of death for CVD patients from 2003 to 2017, finding that home has surpassed the hospital as the most common place of death for these patients.
Ultrasound: The potential power for cardiovascular disease therapy
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 2, pp.
Despite the ACA, millions of Americans with cardiovascular disease still can't get care
Cardiovascular disease (CVD) is the leading cause of death for Americans, yet millions with CVD or cardiovascular risk factors (CVRF) still can't access the care they need, even years after the implementation of the Affordable Care Act (ACA).
Excess weight and body fat cause cardiovascular disease
In the first Mendelian randomization study to look at this, researchers have found evidence that excess weight and body fat cause a range of heart and blood vessel diseases (rather than just being associated with it).
Disease remission associated with 80% reduction in risk of cardiovascular outcomes
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2019) demonstrate that remission in patients with rheumatoid arthritis is associated with an 80% reduction in risk of cardiovascular outcomes.
More Cardiovascular Disease News and Cardiovascular Disease Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...